Get started
Author

Renpei Kato

Observed names: Kato, Renpei, R. Kato, RENPEI KATO
ORCID: 0000-0001-6089-7620
Observed ORCID: 0000-0001-6089-7620
OpenAlex ID: A5036169277
Present status and future perspective of peptide‐based vaccine therapy for urological cancer
2018 · Wataru Obara, Mitsugu Kanehira, et al. · Cancer Science · 56
PDF
Prognostic outcomes and safety in patients treated with pembrolizumab for advanced urothelial carcinoma: experience in real-world clinical practice
2020 · Daichi Tamura, Noriaki Jinnouchi, et al. · International Journal of Clinical Oncology · 47
Phase I clinical trial of cell division associated 1 ( CDCA 1) peptide vaccination for castration resistant prostate cancer
2017 · Wataru Obara, Fuminori Sato, et al. · Cancer Science · 45
PDF
Postoperative recurrence detection using individualized circulating tumor DNA in upper tract urothelial carcinoma
2023 · Daichi Tamura, Masakazu Abe, et al. · Cancer Science · 34
PDF
Appropriate preoperative membranous urethral length predicts recovery of urinary continence after robot-assisted laparoscopic prostatectomy
2018 · Daiki Ikarashi, Yoichiro Kato, et al. · World Journal of Surgical Oncology · 32
PDF
Pretreatment tumour immune microenvironment predicts clinical response and prognosis of muscle-invasive bladder cancer in the neoadjuvant chemotherapy setting
2021 · Daiki Ikarashi, Shigehisa Kitano, et al. · British Journal of Cancer · 28
TIM3 expression on tumor cells predicts response to anti-PD-1 therapy for renal cancer
2020 · Renpei Kato, Noriaki Jinnouchi, et al. · Translational Oncology · 26
PDF
Improvement of three-dimensional motion sickness using a virtual reality simulator for robot-assisted surgery in undergraduate medical students: A prospective observational study
2021 · Ryo Takata, Mitsugu Kanehira, et al. · BMC Medical Education · 19
PDF
Immunotherapy with cancer peptides in combination with intravesical bacillus Calmette–Guerin for patients with non-muscle invasive bladder cancer
2018 · Wataru Obara, Isao Hara, et al. · Cancer Immunology Immunotherapy · 19
Effective induction of cytotoxic T cells recognizing an epitope peptide derived from hypoxia-inducible protein 2 (HIG2) in patients with metastatic renal cell carcinoma
2016 · Wataru Obara, Takashi Karashima, et al. · Cancer Immunology Immunotherapy · 19
PDF
Novel combination chemotherapy with radiotherapy for prostate squamous cell carcinoma
2016 · Mitsutaka Onoda, Ryo Sugimoto, et al. · International Cancer Conference Journal · 17
PDF
Real-world effectiveness of nivolumab plus ipilimumab and second-line therapy in Japanese untreated patients with metastatic renal cell carcinoma: 2-year analysis from a multicenter retrospective clinical study (J-cardinal study)
2022 · Takahiro Kojima, Renpei Kato, et al. · Japanese Journal of Clinical Oncology · 16
PDF
Outcomes of axitinib versus sunitinib as first‐line therapy to patients with metastatic renal cell carcinoma in the immune‐oncology era
2021 · Kazuyuki Numakura, Yumin Muto, et al. · Cancer Medicine · 16
Impact of cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma receiving systemic tyrosine kinase inhibitor therapy: A multicenter retrospective study
2020 · Shingo Hatakeyama, Sei Naito, et al. · International Journal of Urology · 15
PDF
Association between nocturnal polyuria and 24‐h blood pressure fluctuations in males with lower urinary tract symptoms: A multicenter prospective study
2023 · Yoichiro Kato, Hidenori Akaihata, et al. · International Journal of Urology · 14
Impact of germline HLA genotypes on clinical outcomes in patients with urothelial cancer treated with pembrolizumab
2022 · Shuhei Takahashi, Shintaro Narita, et al. · Cancer Science · 14
PDF
Recent progress in immunotherapy for urological cancer
2017 · Wataru Obara, Renpei Kato, et al. · International Journal of Urology · 13
Characteristics of early-onset hematotoxicity of sunitinib in Japanese patients with renal cell carcinoma
2017 · Renpei Kato, Yoichiro Kato, et al. · BMC Cancer · 13
PDF
The Clinical Validity of Urinary Pellet DNA Monitoring for the Diagnosis of Recurrent Bladder Cancer
2024 · Masakazu Abe, Hayato Hiraki, et al. · Journal of Molecular Diagnostics · 12
A Multicentre Retrospective Study of Nivolumab Plus Ipilimumab for Untreated Metastatic Renal Cell Carcinoma
2021 · RENPEI KATO, TAKAHIRO KOJIMA, et al. · Anticancer Research · 11
Efficacy of Everolimus in Patients with Advanced Renal Cell Carcinoma Refractory or Intolerant to VEGFR-TKIs and Safety Compared with Prior VEGFR-TKI Treatment
2014 · Renpei Kato, Wataru Obara, et al. · Japanese Journal of Clinical Oncology · 11
Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era – a multi-institutional retrospective study
2022 · Renpei Kato, Sei Naito, et al. · International Journal of Clinical Oncology · 10
PDF
Prognosis of Japanese metastatic renal cell carcinoma patients in the targeted therapy era
2021 · Sei Naito, Tomoyuki Kato, et al. · International Journal of Clinical Oncology · 10
Complete Pathological Response to Neoadjuvant Pembrolizumab in a Patient With Chemoresistant Upper Urinary Tract Urothelial Carcinoma: A Case Report
2020 · Daiki Ikarashi, Shigehisa Kitano, et al. · Frontiers in Oncology · 10
PDF
Pathological complete response to neoadjuvant chemotherapy may improve antitumor immune response via reduction of regulatory T cells in muscle-invasive bladder cancer
2024 · Daiki Ikarashi, Shigehisa Kitano, et al. · Scientific Reports · 9
PDF
Works count: 141
Citation count: 681
H-index: 14
I10-index: 24
Year
Topic
Type